We are live on ! Find out more
AUTL

Autolus Therapeutics
AUTL

99 hedge funds and large institutions have $747M invested in Autolus Therapeutics in 2023 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 21 increasing their positions, 19 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

7,157% more call options, than puts

Call options by funds: $1.52M | Put options by funds: $21K

580% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 5

189% more capital invested

Capital invested by funds: $258M → $747M (+$489M)

39% more funds holding

Funds holding: 71 → 99 (+28)

11% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 19

2.67% more ownership

Funds ownership: 64% → 66.67% (+2.7%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

Holders
99
Holders Change
+28
Holders Change %
+39.44%
% of All Funds
1.44%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
34
Increased
21
Reduced
19
Closed
5
Calls
$1.52M
Puts
$21K
Net Calls
+$1.5M
Net Calls Change
+$1.14M

Top Buyers

Rank Fund Capital Flow
1
CAM
Cormorant Asset Management
Massachusetts
+$19.3M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$14.6M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$11.4M
4
PA
Perceptive Advisors
New York
+$6.98M
5
FAM
Fred Alger Management
New York
+$5.17M

Top Sellers

Rank Fund Capital Flow
1
TAM
TFG Asset Management
Cayman Islands
-$15.3M
2
DTC
Deep Track Capital
Connecticut
-$11.9M
3
AC
Armistice Capital
New York
-$11.6M
4
PBA
Paradigm Biocapital Advisors
New York
-$6.85M
5
DCM
DAFNA Capital Management
California
-$2.81M
Name Holding Trade Value Shares
Change 		Change in
Stake
State Street
51
State Street
Massachusetts
$337K – – –
LSA
52
Leonteq Securities AG
Switzerland
$322K – – –
BG
53
Bellevue Group
Switzerland
$322K +$191K +50,000 New
Capstone Investment Advisors
54
Capstone Investment Advisors
New York
$322K +$191K +50,000 New
ETC
55
Exchange Traded Concepts
Oklahoma
$315K +$47.2K +12,387 +34%
Walleye Trading
56
Walleye Trading
New York
$287K +$170K +44,633 New
WE
57
Wealth Effects
Massachusetts
$277K -$15.3K -4,000 -9%
SSA
58
Sierra Summit Advisors
Nevada
$275K +$163K +42,744 New
Bank of America
59
Bank of America
North Carolina
$266K +$155K +40,669 +6,538%
LPL Financial
60
LPL Financial
California
$261K +$835 +219 +0.5%
Citadel Advisors
61
Citadel Advisors
Florida
$256K +$152K +39,765 New
PFM
62
Privium Fund Management
Netherlands
$239K – – –
TCOT
63
Trust Company of Toledo
Ohio
$234K – – –
CSS
64
Cubist Systematic Strategies
Connecticut
$206K +$122K +31,969 New
BC
65
BIT Capital
Germany
$194K +$115K +30,063 New
BFM
66
Boothbay Fund Management
New York
$192K – – –
Two Sigma Advisers
67
Two Sigma Advisers
New York
$191K +$17.2K +4,500 +18%
JP Morgan Chase
68
JP Morgan Chase
New York
$177K +$104K +27,327 +25,780%
William Blair & Company
69
William Blair & Company
Illinois
$175K +$53.4K +14,000 +107%
EL
70
EWA LLC
Pennsylvania
$155K +$28.1K +7,361 +40%
Osaic Holdings
71
Osaic Holdings
Arizona
$141K +$13.6K +3,563 +19%
Arrowstreet Capital
72
Arrowstreet Capital
Massachusetts
$137K +$81.3K +21,328 New
Envestnet Asset Management
73
Envestnet Asset Management
Illinois
$136K +$80.7K +21,171 New
CUAMC
74
China Universal Asset Management Company
China
$105K +$62K +16,263 New
Simplex Trading
75
Simplex Trading
Illinois
$88K -$16.5K -4,336 -24%
1 2
3
4 5

AUTL Hedge Fund Activity: Q4 2023 in Review

99 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Autolus Therapeutics (AUTL) for Q4 2023, worth a combined $747M — up 189% from $258M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new AUTL positions and 5 closed out — a net gain of 29 holders — while 21 added to existing stakes and 19 trimmed.

The largest buyer was Cormorant Asset Management, adding an estimated $19.3M. The largest seller was TFG Asset Management, cutting an estimated $15.3M.

  • 99 institutional investors held Autolus Therapeutics (AUTL) as of Q4 2023, up from 71 in Q3 2023.
  • Funds reported $747M of Autolus Therapeutics stock for Q4 2023, up 189% quarter-over-quarter.
  • 34 funds opened new Autolus Therapeutics positions in Q4 2023 and 5 closed out, a net change of +29 holders.
  • The largest Autolus Therapeutics buyer in Q4 2023 was Cormorant Asset Management, an estimated $19.3M added.
  • The largest Autolus Therapeutics seller in Q4 2023 was TFG Asset Management, an estimated $15.3M sold.

Based on aggregated 13F filings for Q4 2023.